Logan E. Finger MD, Alan E. Wilson MD, Brandon K. Couch MD, Alexander P. Hoffman MD, Confidence Njoku-Austin BS, Brian A. Klatt MD, Michael J. O’Malley MD, Johannes F. Plate MD, PhD
{"title":"Real Component Spacers for Two-Stage Exchange Demonstrate Low Bacterial Colonization","authors":"Logan E. Finger MD, Alan E. Wilson MD, Brandon K. Couch MD, Alexander P. Hoffman MD, Confidence Njoku-Austin BS, Brian A. Klatt MD, Michael J. O’Malley MD, Johannes F. Plate MD, PhD","doi":"10.1016/j.artd.2025.101633","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Patients undergoing two-stage exchange arthroplasty for chronic periprosthetic joint infection (PJI) with real component spacers (RC) benefit from improved function. While RCs have similar reinfection rates compared to other spacer types, concerns exist regarding the potential for bacterial colonization and biofilm formation on the RC metal components.</div></div><div><h3>Methods</h3><div>Patients who completed two-stage exchange arthroplasty for treatment of Musculoskeletal Infection Society-defined hip or knee PJI were included and explanted spacer components were sent for sonication fluid culture (SFC). Medical records were reviewed for demographics, laboratory values, culture results, and clinical outcome data including 90-day reoperations and all-cause revisions.</div></div><div><h3>Results</h3><div>A total of 112 patients (57 hips and 64 knees) were included. Sixty (49.6%) patients received an articulating cement spacer (AC), 35 (28.9%) received an RC, and 26 (21.5%) received a static spacer (SS). No positive SFCs were identified with RC compared to 18.3% with AC and 11.5% with SS (<em>P</em> = .01). The number of positive tissue cultures was similar (RC 8.6%, AC 1.7%, SS 3.8%; <em>P</em> = .18). No patients who received an RC required repeat debridement within 90 days, while 11.8% with AC and 4.5% with SS required repeat debridement (<em>P</em> = .14). The difference in the rate of all-cause revision and revision due to recurrent infection among the 3 groups was found to be similar (<em>P</em> = .43 and <em>P</em> = .50, respectively).</div></div><div><h3>Conclusions</h3><div>RC showed fewer SFCs when compared to AC and SS, though there was no significant difference in positive tissue cultures, reoperation within 90 days, all-cause revision, or revision due to recurrent infection among the groups.</div></div>","PeriodicalId":37940,"journal":{"name":"Arthroplasty Today","volume":"32 ","pages":"Article 101633"},"PeriodicalIF":1.5000,"publicationDate":"2025-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Arthroplasty Today","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2352344125000202","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ORTHOPEDICS","Score":null,"Total":0}
引用次数: 0
Abstract
Background
Patients undergoing two-stage exchange arthroplasty for chronic periprosthetic joint infection (PJI) with real component spacers (RC) benefit from improved function. While RCs have similar reinfection rates compared to other spacer types, concerns exist regarding the potential for bacterial colonization and biofilm formation on the RC metal components.
Methods
Patients who completed two-stage exchange arthroplasty for treatment of Musculoskeletal Infection Society-defined hip or knee PJI were included and explanted spacer components were sent for sonication fluid culture (SFC). Medical records were reviewed for demographics, laboratory values, culture results, and clinical outcome data including 90-day reoperations and all-cause revisions.
Results
A total of 112 patients (57 hips and 64 knees) were included. Sixty (49.6%) patients received an articulating cement spacer (AC), 35 (28.9%) received an RC, and 26 (21.5%) received a static spacer (SS). No positive SFCs were identified with RC compared to 18.3% with AC and 11.5% with SS (P = .01). The number of positive tissue cultures was similar (RC 8.6%, AC 1.7%, SS 3.8%; P = .18). No patients who received an RC required repeat debridement within 90 days, while 11.8% with AC and 4.5% with SS required repeat debridement (P = .14). The difference in the rate of all-cause revision and revision due to recurrent infection among the 3 groups was found to be similar (P = .43 and P = .50, respectively).
Conclusions
RC showed fewer SFCs when compared to AC and SS, though there was no significant difference in positive tissue cultures, reoperation within 90 days, all-cause revision, or revision due to recurrent infection among the groups.
期刊介绍:
Arthroplasty Today is a companion journal to the Journal of Arthroplasty. The journal Arthroplasty Today brings together the clinical and scientific foundations for joint replacement of the hip and knee in an open-access, online format. Arthroplasty Today solicits manuscripts of the highest quality from all areas of scientific endeavor that relate to joint replacement or the treatment of its complications, including those dealing with patient outcomes, economic and policy issues, prosthetic design, biomechanics, biomaterials, and biologic response to arthroplasty. The journal focuses on case reports. It is the purpose of Arthroplasty Today to present material to practicing orthopaedic surgeons that will keep them abreast of developments in the field, prove useful in the care of patients, and aid in understanding the scientific foundation of this subspecialty area of joint replacement. The international members of the Editorial Board provide a worldwide perspective for the journal''s area of interest. Their participation ensures that each issue of Arthroplasty Today provides the reader with timely, peer-reviewed articles of the highest quality.